Description: Personalized cancer therapy is a treatment strategy centered on the ability to predict which patients are more likely to respond to specific cancer therapies. This approach is founded upon the idea that tumor biomarkers are associated with patient prognosis and tumor response to therapy. In addition, patient genetic factors can be associated with drug metabolism, drug response and drug toxicity. Personalized tumor molecular profiles, tumor disease site and other patient characteristics are then potentially
gene (170) biomarker (42) dna sequencing (36) targeted therapy (14) genomic medicine (5) cancer genes (1) gene selected (1) gene relevant (1) predicts therapy response (1) molecular profile (1)
You are using an outdated browser. Please upgrade your browser or activate Google Chrome Frame to improve your experience.
© 2023 The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 | 1-877-632-6789 | 1-713-792-6161 International